Short Interest in Ralliant Corporation (NYSE:RAL) Expands By 21.8%

Ralliant Corporation (NYSE:RAL) was the target of a large growth in short interest in the month of February. As of February 13th, there was short interest totaling 4,566,002 shares, a growth of 21.8% from the January 29th total of 3,747,948 shares. Approximately 4.0% of the shares of the company are sold short. Based on an average trading volume of 3,777,582 shares, the short-interest ratio is presently 1.2 days. Based on an average trading volume of 3,777,582 shares, the short-interest ratio is presently 1.2 days. Approximately 4.0% of the shares of the company are sold short.

Insider Activity at Ralliant

In related news, Director Kevin E. Bryant acquired 1,250 shares of the stock in a transaction that occurred on Friday, February 6th. The shares were bought at an average price of $39.97 per share, for a total transaction of $49,962.50. Following the completion of the transaction, the director directly owned 4,653 shares in the company, valued at approximately $185,980.41. This trade represents a 36.73% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Kate Mitchell bought 2,350 shares of the company’s stock in a transaction that occurred on Tuesday, February 10th. The stock was bought at an average price of $42.48 per share, for a total transaction of $99,828.00. Following the acquisition, the director directly owned 8,411 shares of the company’s stock, valued at $357,299.28. The trade was a 38.77% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have acquired a total of 8,145 shares of company stock worth $332,233 over the last quarter.

Institutional Investors Weigh In On Ralliant

A number of hedge funds have recently made changes to their positions in the company. Envestnet Asset Management Inc. bought a new position in shares of Ralliant in the 2nd quarter valued at about $4,922,000. Bessemer Group Inc. purchased a new stake in Ralliant during the second quarter valued at approximately $108,000. Y Intercept Hong Kong Ltd purchased a new stake in Ralliant during the second quarter valued at approximately $623,000. Teacher Retirement System of Texas bought a new stake in shares of Ralliant in the 2nd quarter valued at approximately $835,000. Finally, Keybank National Association OH purchased a new position in shares of Ralliant in the 2nd quarter worth approximately $798,000.

Ralliant Price Performance

NYSE:RAL opened at $47.01 on Thursday. The business’s 50-day simple moving average is $49.18 and its two-hundred day simple moving average is $46.63. Ralliant has a 52 week low of $37.27 and a 52 week high of $57.02. The stock has a market cap of $5.25 billion and a PE ratio of 23.98. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.38.

Ralliant (NYSE:RAL) last released its earnings results on Wednesday, February 4th. The company reported $0.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.67 by $0.02. The business had revenue of $554.60 million for the quarter, compared to analysts’ expectations of $543.04 million. The company’s quarterly revenue was up 1.2% compared to the same quarter last year. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 23rd. Stockholders of record on Monday, March 9th will be given a dividend of $0.05 per share. The ex-dividend date is Monday, March 9th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.4%. Ralliant’s dividend payout ratio (DPR) is presently 10.20%.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the stock. Citigroup reduced their target price on shares of Ralliant from $61.00 to $51.00 and set a “buy” rating for the company in a report on Friday, February 6th. Zacks Research downgraded shares of Ralliant from a “hold” rating to a “strong sell” rating in a research report on Monday, February 9th. Truist Financial reduced their price objective on Ralliant from $62.00 to $49.00 and set a “buy” rating for the company in a research note on Friday, February 6th. Morgan Stanley reaffirmed an “overweight” rating and issued a $45.00 target price on shares of Ralliant in a report on Friday, February 6th. Finally, Royal Bank Of Canada cut their price target on Ralliant from $52.00 to $41.00 and set a “sector perform” rating for the company in a report on Friday, February 6th. Seven analysts have rated the stock with a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $50.50.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.